2023
Individualised variable-interval risk-based screening in diabetic retinopathy: the ISDR research programme including RCT (Journal article)
Harding, S., Alshukri, A., Appelbe, D., Broadbent, D., Burgess, P., Byrne, P., . . . Williamson, P. (2023). Individualised variable-interval risk-based screening in diabetic retinopathy: the ISDR research programme including RCT.
Defres, S., Tharmaratnam, K., Michael, B. D., Ellul, M., Davies, N. W. S., Easton, A., . . . Solomon, T. (2023). Clinical predictors of encephalitis in UK adults-A multi-centre prospective observational cohort study.. PloS one, 18(8), e0282645. doi:10.1371/journal.pone.0282645DOI: 10.1371/journal.pone.0282645
Burnside, G., Cheyne, C. P., Leeming, G., Humann, M., Darby, A., Green, M. A., . . . Buchan, I. E. (2023). COVID-19 risk-mitigation in reopening mass cultural events: population-based observational study for the UK Events Research Programme in Liverpool City Region. Journal of the Royal Society of Medicine. doi:10.1177/01410768231182389DOI: 10.1177/01410768231182389
Hughes, D. M., Bird, S. M., Cheyne, C. P., Ashton, M., Campbell, M. C., Garcia-Finana, M., & Buchan, I. (2023). Rapid antigen testing in COVID-19 management for school-aged children: an observational study in Cheshire and Merseyside, UK. JOURNAL OF PUBLIC HEALTH, 45(1), E38-E47. doi:10.1093/pubmed/fdac003DOI: 10.1093/pubmed/fdac003
Hughes, D., Cheyne, C., Ashton, M., Coffee, E., Crozier, A., Semple, M., . . . Garcia-Finana, M. (n.d.). Association of SARS-CoV-2 viral load distributions with individual demographics and suspected variant type: Results from the Liverpool Community Testing Pilot - England, 6 November 2020‒8 September 2021. Eurosurveillance. doi:10.2807/1560-7917.ES.2023.28.4.2200129DOI: 10.2807/1560-7917.ES.2023.28.4.2200129
2022
Green, M. A., Hungerford, D. J., Hughes, D. M., Garcia-Finana, M., Turtle, L., Cheyne, C., . . . Buchan, I. (2022). Changing patterns of SARS-CoV-2 infection through Delta and Omicron waves by vaccination status, previous infection and neighbourhood deprivation: a cohort analysis of 2.7 M people. BMC INFECTIOUS DISEASES, 22(1). doi:10.1186/s12879-022-07878-2DOI: 10.1186/s12879-022-07878-2
Phase I/II Clinical Trials of Donor-Derived Purified Regulatory T Cells for the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease (Conference Paper)
Soares, M. V., Gomez, V. E., Azevedo, R. I., Pereira, P. N. G., Velazquez, T. C., Garcia-Calderon, C. B., . . . Lacerda, J. F. (2022). Phase I/II Clinical Trials of Donor-Derived Purified Regulatory T Cells for the Treatment of Steroid-Refractory Chronic Graft Versus Host Disease. In BLOOD Vol. 140. doi:10.1182/blood-2022-163394DOI: 10.1182/blood-2022-163394
Marsden, L., Hughes, D. M., Corcoran, R., Cheyne, C. P., Ashton, M., Buchan, I., . . . Garcia-Finana, M. (2022). Daily testing of contacts of SARS-CoV-2 infected cases as an alternative to quarantine for key workers in Liverpool: A prospective cohort study. ECLINICALMEDICINE, 50. doi:10.1016/j.eclinm.2022.101519DOI: 10.1016/j.eclinm.2022.101519
Pattni, K., Hungerford, D., Adams, S., Buchan, I., Cheyne, C. P., García-Fiñana, M., . . . Sharkey, K. J. (n.d.). Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2. BMC Infectious Diseases, 22(1). doi:10.1186/s12879-022-07239-zDOI: 10.1186/s12879-022-07239-z
2021
Cheyne, C. P., Burgess, P. I., Broadbent, D. M., Garcia-Finana, M., Stratton, I. M., Criddle, T., . . . Harding, S. P. (2021). Incidence of sight-threatening diabetic retinopathy in an established urban screening programme: An 11-year cohort study. DIABETIC MEDICINE, 38(9). doi:10.1111/dme.14583DOI: 10.1111/dme.14583
Garcia-Finana, M., Hughes, D. M., Cheyne, C. P., Burnside, G., Stockbridge, M., Fowler, T. A., . . . Buchan, I. (2021). Performance of the Innova SARS-CoV-2 antigen rapid lateral flow test in the Liverpool asymptomatic testing pilot: population based cohort study. BMJ-BRITISH MEDICAL JOURNAL, 374. doi:10.1136/bmj.n1637DOI: 10.1136/bmj.n1637
Docherty, A., Mulholland, R., Lone, N. I., Cheyne, C., De Angelis, D., Diaz-Ordaz, K., . . . Semple, M. (2021). Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK. LANCET RESPIRATORY MEDICINE, 9(7), 773-785. doi:10.1016/S2213-2600(21)00175-2DOI: 10.1016/S2213-2600(21)00175-2
Green, M. A., Garcia-Finana, M., Barr, B., Burnside, G., Cheyne, C. P., Hughes, D., . . . Buchan, I. E. (2021). Evaluating social and spatial inequalities of large scale rapid lateral flow SARS-CoV-2 antigen testing in COVID-19 management: An observational study of Liverpool, UK (November 2020 to January 2021). LANCET REGIONAL HEALTH-EUROPE, 6. doi:10.1016/j.lanepe.2021.100107DOI: 10.1016/j.lanepe.2021.100107
Romdhoniyyah, D. F., Harding, S. P., Cheyne, C. P., & Beare, N. A. V. (2021). Metformin, A Potential Role in Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. OPHTHALMOLOGY AND THERAPY, 10(2), 245-260. doi:10.1007/s40123-021-00344-3DOI: 10.1007/s40123-021-00344-3
García-Fiñana, M., Hughes, D. M., Cheyne, C., Burnside, G., Stockbridge, M., Fowler, T. A., . . . Buchan, I. (2021). Performance of the Innova SARS-CoV-2 Antigen Rapid Lateral Flow Test in the Liverpool Asymptomatic Testing Pilot. doi:10.2139/ssrn.3798558DOI: 10.2139/ssrn.3798558
Green, M., Garcia-Finana, M., Barr, B., Burnside, G., Cheyne, C., Hughes, D., . . . Buchan, I. (2021). Evaluating Social and Spatial Inequalities of Large Scale Rapid Lateral Flow SARS-CoV-2 Antigen Testing in COVID-19 Management: An Observational Study of Liverpool, UK (November 2020 to January 2021). doi:10.2139/ssrn.3786003DOI: 10.2139/ssrn.3786003
Romdhoniyyah, D., Cheyne, C. P., Alshukri, A., Parry, D. G., Finana, M. G., Harding, S. P., & Beare, N. A. V. (2021). Five-Year Incidence and Progression of Age-Related Macular Degeneration in People with Diabetes. In EUROPEAN JOURNAL OF OPHTHALMOLOGY Vol. 31 (pp. 4). Retrieved from https://www.webofscience.com/
Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT (Journal article)
Broadbent, D., Wang, A., Cheyne, C., James, M., Lathe, J., Stratton, I., . . . Harding, S. (2021). Safety and cost-effectiveness of individualised screening for diabetic retinopathy: the ISDR open-label, equivalence RCT. Diabetologia, 64(1), 56-69. doi:10.1007/s00125-020-05313-2DOI: 10.1007/s00125-020-05313-2
2019
Methodological aspects of the ISDR RCT: Investigating individualised variable interval screening for diabetic retinopathy in a screening population (Poster)
Cheyne, C. P., Broadbent, D. M., Moitt, T., Howard, L., Howlin, S., Silvera, K., . . . Garcia-Finana, M. (2019). Methodological aspects of the ISDR RCT: Investigating individualised variable interval screening for diabetic retinopathy in a screening population. Poster session presented at the meeting of Unknown Conference. Retrieved from https://www.webofscience.com/
Broadbent, D. M., Sampson, C. J., Wang, A., Howard, L., Williams, A. E., Howlin, S. U., . . . Harding, S. P. (2019). Individualised screening for diabetic retinopathy: the ISDR study - rationale, design and methodology for a randomised controlled trial comparing annual and individualised risk-based variable-interval screening. BMJ OPEN, 9(6). doi:10.1136/bmjopen-2018-025788DOI: 10.1136/bmjopen-2018-025788
Broadbent, D. M., Wang, A., Cheyne, C. P., Lathe, J. G., Stratton, I. M., Vora, J., . . . Harding, S. P. (2019). Individualised Screening for Diabetic Retinopathy: The ISDR Study-A Randomised Controlled Trial of Safety, Efficacy, and Cost-Effectiveness. In DIABETES Vol. 68. doi:10.2337/db19-39-LBDOI: 10.2337/db19-39-LB
Broadbent, D., Wang, A., Cheyne, C. P., James, M., Lathe, J. G., Stratton, I. M., . . . Harding, S. P. (2019). Safety, Efficacy and Cost Effectiveness of Individualised Screening for Diabetic Retinopathy: The ISDR Randomised Controlled Trial.
Rowe, F. J., Hepworth, L. R., Howard, C., Hanna, K. L., Cheyne, C. P., & Currie, J. (2019). High incidence and prevalence of visual problems after acute stroke: an epidemiology study with implications for service delivery. PLoS One, 14(3). doi:10.1371/journal.pone.0213035DOI: 10.1371/journal.pone.0213035
Garcia-Finana, M., Hughes, D., Cheyne, C. P., Broadbent, D. M., wang., Wang, A., . . . Harding, S. (2019). Personalized risk‐based screening for diabetic retinopathy: A multivariate approach versus the use of stratification rules. Diabetes, Obesity and Metabolism, 21(3), 560-568. doi:10.1111/dom.13552DOI: 10.1111/dom.13552
2017
Individualised variable interval risk-based screening for sight threatening diabetic retinopathy – the Liverpool Risk Calculation Engine (Journal article)
Harding, S. P., Eleuteri, A., Fisher, A. C., Broadbent, D. M., Garcia-Finana, M., Cheyne, C. P., . . . Seddon, D. (2017). Individualised variable interval risk-based screening for sight threatening diabetic retinopathy – the Liverpool Risk Calculation Engine. Diabetologia, 60(11), 2174-2182. doi:10.1007/s00125-017-4386-0DOI: 10.1007/s00125-017-4386-0
A novel multivariate discriminant approach to predict sight threatening diabetic retinopathy (STDR) cases - data from the Liverpool Diabetic Eye Study (Conference Paper)
Garcia-Finana, M., Hughes, D. M., Cheyne, C. P., Broadbent, D. M., Wang, A., Mobayen-Rahni, M., . . . Harding, S. P. (2017). A novel multivariate discriminant approach to predict sight threatening diabetic retinopathy (STDR) cases - data from the Liverpool Diabetic Eye Study. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Vol. 58. Retrieved from https://www.webofscience.com/
Harding, S. P., Cheyne, C. P., Broadbent, D. M., Appelbe, D., Wang, A., Rahni, M., . . . Finana, M. G. (2017). SAFETY OF INDIVIDUALISED VARIABLE INTERVAL SCREENING FOR REFERABLE DIABETIC RETINOPATHY: BASELINE DATA FROM THE ISDR RANDOMISED CONTROLLED STUDY. In EUROPEAN JOURNAL OF OPHTHALMOLOGY Vol. 27 (pp. E126). Retrieved from https://www.webofscience.com/
2016
Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate (Journal article)
Bromley, R., Calderbank, R., Cheyne, C. P., Rooney, C., Trayner, P., Cohen., . . . Baker, G. A. (2016). Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate. Neurology, 87(18). doi:10.1212/WNL.0000000000003157DOI: 10.1212/WNL.0000000000003157
Discriminant Function Analysis for Longitudinal Data (DiALog): Applications in Medical Research (Poster)
Hughes., Czanner, G., Cox, T., Bonnett, L., Harding, S., Marson, A., . . . Van der Hoek, M. (2016). Discriminant Function Analysis for Longitudinal Data (DiALog): Applications in Medical Research. Poster session presented at the meeting of 2016 MRC Festival of Medical Science. Liverpool.
10 YEAR OBSERVATIONAL STUDY OF PATIENT RELATED OUTCOMES DURING EXPANSION TO FULL POPULATION COVERAGE OF A SYSTEMATIC DIABETES EYE CARE PROGRAMME - THE LIVERPOOL DIABETIC EYE STUDY (Conference Paper)
Harding, S. P., Sampson, C., Cheyne, C. P., Broadbent, D. M., Stratton, I. M., Wang, A., & Garcia Finana, M. (2016). 10 YEAR OBSERVATIONAL STUDY OF PATIENT RELATED OUTCOMES DURING EXPANSION TO FULL POPULATION COVERAGE OF A SYSTEMATIC DIABETES EYE CARE PROGRAMME - THE LIVERPOOL DIABETIC EYE STUDY. In EUROPEAN JOURNAL OF OPHTHALMOLOGY Vol. 26 (pp. E98). Retrieved from https://www.webofscience.com/
Harding, S. P., Sampson, C., Cheyne, C., Broadbent, D., Wang, A., Mobayen-Rahni, M., . . . Finana, M. G. (2016). 10 year observational study of patient related outcomes during expansion to full population coverage of a systematic diabetes eye care programme - the Liverpool Diabetic Eye Study. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Vol. 57. Retrieved from https://www.webofscience.com/
2015
Hughes, D., Czanner, G., Cheyne, C., Komarek, A., Harding, S., & Garcia Finana, M. (2015). Personalised Longitudinal Discriminant Analysis for Early Detection of Diabetic Retinopathy. Poster session presented at the meeting of ITM Research Day. University of Liverpool.
Harding, S. P., Eleuteri, A., Broadbent, D. M., van der Hoek, M., Cheyne, C. P., Wang, A., . . . Fisher, A. C. (2015). Individualised risk-based screening for sight threatening diabetic retinopathy - the Liverpool Risk Calculation Engine. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE Vol. 56. Retrieved from https://www.webofscience.com/
Rowe, F. J., Cheyne, C. P., Garcia-Finana, M., Noonan, C. P., Howard, C., Smith, J., & Adeoye, J. (2015). Detection of Visual Field Loss in Pituitary Disease: Peripheral Kinetic Versus Central Static. NEURO-OPHTHALMOLOGY, 39(3), 116-124. doi:10.3109/01658107.2014.990985DOI: 10.3109/01658107.2014.990985
Sampson, C. J., Tosh, J. C., Cheyne, C. P., Broadbent, D., & James, M. (2015). Health state utility values for diabetic retinopathy: protocol for a systematic review and meta-analysis. SYSTEMATIC REVIEWS, 4. doi:10.1186/s13643-015-0006-6DOI: 10.1186/s13643-015-0006-6
INDIVIDUALISED RISK-BASED SCREENING FOR DIABETIC RETINOPATHY – THE LIVERPOOL RISK CALCULATION ENGINE (Conference Paper)
Harding, S. P., Eleuteri, A., Broadbent, D. M., Van der Hoek, M., Cheyne, C., Wang, A., . . . Fisher, A. C. (2015, June 26). INDIVIDUALISED RISK-BASED SCREENING FOR DIABETIC RETINOPATHY – THE LIVERPOOL RISK CALCULATION ENGINE. In European Journal of Ophthalmology Vol. 25 (pp. e7-e30). Turin. doi:10.5301/ejo.5000612DOI: 10.5301/ejo.5000612
Baker, G. A., Bromley, R. L., Briggs, M., Cheyne, C., Cohen, M. J., García-Fiñana, M., . . . Clayton-Smith, J. (2015). IQ at 6 years after in utero exposure to antiepileptic drugs: A controlled cohort study. Neurology, 84(4), 382-390. doi:10.1212/WNL.0000000000001182DOI: 10.1212/WNL.0000000000001182
INDIVIDUALISED RISK-BASED SCREENING FOR DIABETIC RETINOPATHY: THE LIVERPOOL RISK CALCULATION ENGINE (Journal article)
Harding, S. P., Eleuteri, A., Broadbent, D. M., van der Hoek, M., Cheyne, C. P., Stratton, I. M., & Fisher, A. C. (2015). INDIVIDUALISED RISK-BASED SCREENING FOR DIABETIC RETINOPATHY: THE LIVERPOOL RISK CALCULATION ENGINE. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 25(3), E12-E13. Retrieved from https://www.webofscience.com/
2014
In Utero Exposure to Levetiracetam vs Valproate: Development & Language at 3 years of Age (Journal article)
Shallcross, R., Bromley, R. L., Cheyne, C. P., Garcia-Finana, M., Irwin, B., Morrow, J., & Baker, G. A. (2014). In Utero Exposure to Levetiracetam vs Valproate: Development & Language at 3 years of Age. Neurology, 82(3), 213-221. doi:10.1212/WNL.0000000000000030DOI: 10.1212/WNL.0000000000000030
In utero exposure to levetiracetam vs valproate (Journal article)
Shallcross, R., Bromley, R. L., Cheyne, C. P., García-Fiñana, M., Irwin, B., Morrow, J., & Baker, G. A. (2014). In utero exposure to levetiracetam vs valproate. Neurology, 82(3), 213-221. doi:10.1212/wnl.0000000000000030DOI: 10.1212/wnl.0000000000000030
Musical ability enhances language skills in men and mathematical skills in women (Journal article)
Cheyne, C. P., Sluming, V., Cowell, P. E., Roberts, N., & Garcia-Finana, M. (2014). Musical ability enhances language skills in men and mathematical skills in women.
Octopus and Humphrey perimetry in the detection of visual field loss in pituitary disease: peripheral kinetic versus central static (Journal article)
Rowe, F. J., Cheyne, C. P., GarcÃa-Fiñana, M., Noonan, C. P., Howard, C., Smith, J., & Adeoye, J. (2014). Octopus and Humphrey perimetry in the detection of visual field loss in pituitary disease: peripheral kinetic versus central static.
Prenatal exposure to antiepileptic drugs: Specific cognitive consequences in middle childhood (Journal article)
Bromley, R. L., Gummery, A., Shallcross, R., Mawer, G., Briggs, M., Clayton-Smith, J., . . . Mawer, G. (2014). Prenatal exposure to antiepileptic drugs: Specific cognitive consequences in middle childhood.
2013
The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs (Journal article)
Bromley, R. L., Mawer, G. E., Briggs, M., Cheyne, C., Clayton-Smith, J., Garcia-Finana, M., . . . Shallcross, R. (2013). The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. Journal of Neurology, Neurosurgery & Psychiatry, 84(6), 637-643. doi:10.1136/jnnp-2012-304270DOI: 10.1136/jnnp-2012-304270
The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. (Journal article)
Bromley, R. L., Mawer, G. E., Briggs, M., Cheyne, C., Clayton-Smith, J., García-Fiñana, M., . . . Liverpool and Manchester Neurodevelopment Group. (2013). The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs.. Journal of neurology, neurosurgery, and psychiatry, 84(6), 637-643. doi:10.1136/jnnp-2012-304270DOI: 10.1136/jnnp-2012-304270
